| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB200-125SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB500-230SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB200-128SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76395-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-59407-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-35336-20ul | |||
![Western Blot: PRAS40 Antibody [NBP1-55261] - Reccomended Titration: 0.2 - 1 ug/ml ELISA Titer: 1:62500 Positive Control: 293T cell lysate](http://images.novusbio.com/fullsize/PRAS40-Antibody-Western-Blot-NBP1-55261-img0004.jpg "Western Blot: PRAS40 Antibody [NBP1-55261] - Reccomended Titration: 0.2 - 1 ug/ml ELISA Titer: 1:62500 Positive Control: 293T cell lysate")
![Immunohistochemistry: PRAS40 Antibody [NBP1-55261] - Formalin Fixed Paraffin Embedded Tissue: Human heart Tissue Observed Staining: Cytoplasmic in endothelial cells in blood vessels Primary Antibody Concentration: 1:100 Other Working Concentrations: N/A Secondary Antibody: Donkey anti-Rabbit-Cy3 Secondary Antibody Concentration: 1:200 Magnification: 20X Exposure Time: 0.5 - 2.0 sec](http://images.novusbio.com/fullsize/PRAS40-Antibody-Immunohistochemistry-NBP1-55261-img0003.jpg)
![Western Blot: PUMA Antibody [NB500-230] - WB detection of PUMA in transfected U20S cells using NB500-230 at a dilution of 1:250. Please note that this antibody is expected to detect alpha as well as the beta forms of this target.](http://images.novusbio.com/fullsize/PUMA-Antibody-Western-Blot-NB500-230-img0002.jpg "Western Blot: PUMA Antibody [NB500-230] - WB detection of PUMA in transfected U20S cells using NB500-230 at a dilution of 1:250. Please note that this antibody is expected to detect alpha as well as the beta forms of this target.")
![Western Blot: hHR23A Antibody [NBP1-52920] - Titration: 2.5ug/ml Positive Control: Jurkat cell lysate.](http://images.novusbio.com/fullsize/hHR23A-Antibody-Western-Blot-NBP1-52920-img0005.jpg "Western Blot: hHR23A Antibody [NBP1-52920] - Titration: 2.5ug/ml Positive Control: Jurkat cell lysate.")
![Immunohistochemistry-Paraffin: hHR23A Antibody [NBP1-52920] - Human Lung Alveolar cells (indicated with arrows), 4-8ug/ml.](http://images.novusbio.com/fullsize/hHR23A-Antibody-Immunohistochemistry-Paraffin-NBP1-52920-img0004.jpg)
![Western Blot: FEZ1 Antibody [NBP1-76395] - Analysis of SAPAP2 in Raji cell lysate with SAPAP2 antibody at (A) 0.5 and (B) 1 ug/mL.](http://images.novusbio.com/fullsize/FEZ1-Antibody-Western-Blot-NBP1-76395-img0002.jpg "Western Blot: FEZ1 Antibody [NBP1-76395] - Analysis of SAPAP2 in Raji cell lysate with SAPAP2 antibody at (A) 0.5 and (B) 1 ug/mL.")
![Western Blot: FEZ1 Antibody [NBP1-76395] - SK-N-SH cell lysate with FEZ1 antibody at 1 ug/mL in the (A) presence and (B) absence of blocking peptide.](http://images.novusbio.com/fullsize/FEZ1-Antibody-Western-Blot-NBP1-76395-img0001.jpg)
![ELISA: p62/SQSTM1 ELISA Kit (Colorimetric) [NBP2-61300] - These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.](http://images.novusbio.com/fullsize/p62-SQSTM1-ELISA-Kit-Colorimetric-ELISA-NBP2-61300-img0001.jpg "ELISA: p62/SQSTM1 ELISA Kit (Colorimetric) [NBP2-61300] - These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.")
![ELISA: p62/SQSTM1 ELISA Kit (Colorimetric) [NBP2-61300] - These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.](http://images.novusbio.com/fullsize/p62-SQSTM1-ELISA-Kit-Colorimetric-ELISA-NBP2-61300-img0002.jpg)
![In vitro assay: Recombinant Human SOD1/Cu-Zn SOD Active, Monomer Protein [NBP3-14782] - Thioflavin T assay of SOD1 pre-formed fibrils (PFFs) combined with SOD1 monomers (NBP3-14782). Pre-formed fibrils seed the aggregation of monomers, leading to an increase in Thioflavin T fluorescence](http://images.novusbio.com/fullsize/Recombinant-Human-SOD1-Cu-Zn-SOD-Active--Monomer-Protein-In-vitro-assay-NBP3-14782-img0001.jpg "In vitro assay: Recombinant Human SOD1/Cu-Zn SOD Active, Monomer Protein [NBP3-14782] - Thioflavin T assay of SOD1 pre-formed fibrils (PFFs) combined with SOD1 monomers (NBP3-14782). Pre-formed fibrils seed the aggregation of monomers, leading to an increase in Thioflavin T fluorescence")
![SDS-Page: Recombinant Human SOD1/Cu-Zn SOD Active, Monomer Protein [NBP3-14782] - SDS-PAGE of human SOD1 monomer protein (NBP3-14782). Load: 2 ug](http://images.novusbio.com/fullsize/Recombinant Human SOD1-Cu-Zn SOD Active- Monomer Protein-SDS-Page-NBP3-14782-img0002.jpg)
![Western Blot: MTA2 Antibody [NBP2-87852] - WB Suggested Anti-MTA2 Antibody Titration: 1.25ug/ml. Positive Control: Jurkat cell lysateMTA2 is supported by BioGPS gene expression data to be expressed in Jurkat](http://images.novusbio.com/fullsize/MTA2-Antibody-Western-Blot-NBP2-87852-img0002.jpg "Western Blot: MTA2 Antibody [NBP2-87852] - WB Suggested Anti-MTA2 Antibody Titration: 1.25ug/ml. Positive Control: Jurkat cell lysateMTA2 is supported by BioGPS gene expression data to be expressed in Jurkat")
![Immunohistochemistry: MTA2 Antibody [NBP2-87852] - Human kidney](http://images.novusbio.com/fullsize/MTA2-Antibody-Immunohistochemistry-NBP2-87852-img0001.jpg)
![Western Blot: Park7/DJ-1 Antibody (1E12) [NBP2-59407] - Lane 1: Kidney tissue lysates](http://images.novusbio.com/fullsize/Park7-DJ-1-Antibody-1E12-Western-Blot-NBP2-59407-img0001.jpg "Western Blot: Park7/DJ-1 Antibody (1E12) [NBP2-59407] - Lane 1: Kidney tissue lysates")
![Immunocytochemistry/Immunofluorescence: Park7/DJ-1 Antibody (1E12) [NBP2-59407] - Analysis of PARK7 in Hep3B cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human PARK7 antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green). Analysis of PARK7 in HeLa cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human PARK7 antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).](http://images.novusbio.com/fullsize/Park7-DJ-1-Antibody-1E12-Immunocytochemistry-Immunofluorescence-NBP2-59407-img0002.jpg)
![Western Blot: Aurora A [p Thr288] Antibody [NBP3-05434] - Western blot analysis of extracts of HeLa and HT-29 cells, using Aurora A antibody (NBP3-05434) at 1:1000 dilution. HeLa cells were treated by Hydroxyurea (4mM) for 20 hours. Hela cells were treated by Nocodazole (50ng/mL) for 20 hours.HT-29 cells were treated by Hydroxyurea (4 mM) for 20 hours or treated by Nocodazole (100ng/mL) for 16 hours. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% BSA. Detection: ECL Basic Kit. Exposure time: 90s.](http://images.novusbio.com/fullsize/Aurora-A-[p-Thr288]-Antibody-Western-Blot-NBP3-05434-img0001.jpg "Western Blot: Aurora A [p Thr288] Antibody [NBP3-05434] - Western blot analysis of extracts of HeLa and HT-29 cells, using Aurora A antibody (NBP3-05434) at 1:1000 dilution. HeLa cells were treated by Hydroxyurea (4mM) for 20 hours. Hela cells were treated by Nocodazole (50ng/mL) for 20 hours.HT-29 cells were treated by Hydroxyurea (4 mM) for 20 hours or treated by Nocodazole (100ng/mL) for 16 hours. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% BSA. Detection: ECL Basic Kit. Exposure time: 90s.")
![Simple Western: Aurora A [p Thr288] Antibody - BSA Free [NBP3-05434] - Analysis of protein expression post-drug treatment. (A) CHLA-10 and (B) TC-71 cells treated with drugs were assessed for changes in protein expression 24 h post-treatment via capillary electrophoresis-based Wes analysis. Increased protein levels of KIF11, p-KIF11Thr926 AURKA, and p-AURKAThr288 were observed for the drug combination group, whereas KIF15 levels were noticeably lower. Similarly, enhanced cleaved-PARP expression was observed with the combination treatment. The uncropped blots are shown in Figures S8 and S9. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/37894278 ), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nbp3-05434_rabbit-polyclonal-aurora-a-p-thr288-antibody-308202410445511.jpg)
![Western Blot: Laminin beta 1 Antibody [NBP3-35336] - Western blot analysis of various lysates using Laminin beta 1 Rabbit pAb at 1:1000 dilution.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 10s.](http://images.novusbio.com/fullsize/nbp3-35336_rabbit-laminin-beta-1-pab-101220241233876.jpg "Western Blot: Laminin beta 1 Antibody [NBP3-35336] - Western blot analysis of various lysates using Laminin beta 1 Rabbit pAb at 1:1000 dilution.Secondary antibody: HRP-conjugated Goat anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 10s.")
![Immunocytochemistry/ Immunofluorescence: Laminin beta 1 Antibody [NBP3-35336] - Immunofluorescence analysis of L929 cells using Laminin beta 1 Rabbit pAb at dilution of 1:100 (40x lens). Secondary antibody: Cy3-conjugated Goat anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp3-35336_rabbit-laminin-beta-1-pab-1012202411552810.jpg)